Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)
- Sponsor
- Fudan University
- Study ID
- NCT06031181
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Frozen Section
- Lung Adenocarcinoma
- Sublobar Resection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Sublobar Resection — PROCEDURESublobar Resection includes segmentectomy and wedge resection
Study Details
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1019. The goal of this clinical trial is to confirm the therapeutic effect of sublobar resection for AIS/MIA diagnosed by intraoperative frozen section.
Key Dates
- Start date
- Mar 31, 2023
- Status verified
- Dec 2023
- Primary completion
- Jan 1, 2026
- Completion
- Dec 31, 2030
Study Design
- Enrollment
- 390 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Sublobar resectionSublobar resection is performed for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section
Primary Outcome Measure
5-year recurrence-free survival [ Time Frame: 5 years ]
Central Contacts
- Chaoqiang Deng+86-13122677592
Related Studies
- Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung CancerRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsPHASE1 · Recruiting · Anusha Kalbasi · Duarte, California
- Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerPHASE2 · Recruiting · National Cancer Institute (NCI) · Buena Park, California
- Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical ResectionRecruiting · University of Colorado, Denver · Aurora, Colorado